Significance of Serum Uric Acid in Children with Pulmonary Arterial Hypertension

1. Pezzuto B, Badagliacca R, Poscia R, et al. Circulating biomarkers in pulmonary arterial hypertension: Update and future direction. J Heart Lung Transplant. 2015;34:282-305.10.1016/j.healun.2014.12.00525682555Search in Google Scholar

2. Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation. 2003;107:1991-1997.10.1161/01.CIR.0000065637.10517.A012707250Search in Google Scholar

3. Shimizu Y, Nagaya N, Satoh T, et al. Serum acid uric level increases in proportion to the severity of pulmonary thromboembolism. Circ J. 2002;66:571-575.10.1253/circj.66.57112074276Search in Google Scholar

4. Nagaya N, Uematsu M, Satoh T, et al. Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension. Am J Respir Crit Care Med. 1999;160:487-492.10.1164/ajrccm.160.2.981207810430718Search in Google Scholar

5. Oya H, Nagaya N, Satoh T, et al. Haynamic correlates and pronostic significance of uric acid in adults patients with Eisenmenger syndrome. Heart. 2000;84:53-58.10.1136/heart.84.1.53172941010862589Search in Google Scholar

6. Dimitroulas T, Giannakoulas G, Dimitroula H, et al. Significance of serum uric acid in pulmonary hypertension dueto systemic slerosis: a pilot study. Rheumatol Int. 2011;31:263-267.10.1007/s00296-010-1557-420658290Search in Google Scholar

7. Zang CY, Ma LL, Wang CX. Relationship between serum uric acid levels and ventricular function in patients with idiopathic pulmonary hypertension. Exp Clin Cardiol. 2013;18(1):37-39.Search in Google Scholar

8. Khosla UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endothelium dysfunction. Kidney Int. 2005;67:1739-1742.10.1111/j.1523-1755.2005.00273.x15840020Search in Google Scholar

9. Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2016;37(1):67-11910.1093/eurheartj/ehv31726320113Search in Google Scholar

10. Suteu C, Blesneac C, Toganel R, et al. Epidemiological characteristics and prospective follow-up of children with pulmonary arterial hypertension. Acta Medica Marisiensis. 2015;61(2):75-82.10.1515/amma-2015-0026Search in Google Scholar

11. Opotowsky AR, Clair M, Afilalo J. A simple echocardiographic method to estimate pulmonary vascular resistance. Am J Cardiol. 2013;112:873-882.10.1016/j.amjcard.2013.05.016431736023735649Search in Google Scholar

12. Bendayan D, Shitrit D, Ygla M, et al. Hyperuricemia as a pronostic factor in pulmonary arterial hypertension. Respir Med. 2003;97:130-133.10.1053/rmed.2003.1440Search in Google Scholar

13. Van Albada ME, Loot FG, Fokkema R, et al. Biological serum markers in the management of pediatric pulmonary arterial hypertension. Pediatric Research. 2008;63(3):321-327.10.1203/PDR.0b013e318163a2e7Search in Google Scholar

14. Voelkel MA, Wynne KM, Badesch DB, et al. Hyperuricemia in severe pulmonary hypertension. Chest. 2000;117:19-24.10.1378/chest.117.1.19Search in Google Scholar

15. Bossome E, Bodini BD, Mazza A, et al. Pulmonary arterial hypertension, the key role of echocardiography. Chest. 2005;127:1836-1843.10.1378/chest.127.5.1836Search in Google Scholar

16. Galie N, Hinderliter AL, Torbicki A, et al. Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and Doppler measures in patients with pulmonary arterial hypertension. J Am Coll Cardiol. 2003;41:1380-1386.10.1016/S0735-1097(03)00121-9Search in Google Scholar

17. Colvin KL, Dufva MJ, Delaney RP, et al. Biomarkers for pediatric pulmonary arterial hypertension- a call to collaborate. Frontiers in Pediatrics. 2014;2(7):1-12.10.3389/fped.2014.00007Search in Google Scholar

18. Raymond RJ, Hinderliter AL, Willis PW, et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol. 2002;39:1214-1219.10.1016/S0735-1097(02)01744-8Search in Google Scholar

19. Eysmann SB, Palevsky HI, Reichek N, et al. Two-dimensional and Doppler echocardiography and cardiac catheterisation correlates of survival in primary pulmonary hypertension. Circulation. 1989;80:353-360.10.1161/01.CIR.80.2.3532752562Search in Google Scholar

20. Vonk MC, Sander MH, van der Hoogen, et al. Right ventricle Tei-index: a tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue disease. Eur J Echocardiogr. 2007;8:317-321.10.1016/j.euje.2006.06.00216846757Search in Google Scholar

21. Anavekar NS, Gerson D, Skali H, et al. Two- dimensional assessment of right ventricular function: an echocardiographic-MRI correlative study. Echocardiography. 2007;24(5):452-456.10.1111/j.1540-8175.2007.00424.x17456062Search in Google Scholar

22. Jone PN, Ivy DD. Echocardiography in pediatric pulmonary hypertension. Frontiers in paediatrics. 2014;124(2).10.3389/fped.2014.00124422885025429362Search in Google Scholar